Summary & Overview
CPT 2026F: Validation of Retinal Imaging for Diabetic Retinopathy
CPT code 2026F documents the use of supplementary eye imaging by an ophthalmology or optometry provider to validate seven-standard-field stereoscopic retinal photographs in patients with diabetic retinopathy. This code captures a specific clinical validation and charting activity tied to retinal imaging protocols used in diabetic eye disease management. Nationally, accurate use of this code supports clinical documentation, quality reporting, and appropriate capture of imaging validation services in outpatient eye care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The discussion addresses how payers commonly recognize imaging validation services and what providers should expect in terms of coverage categories and claim submission context.
Readers will learn the clinical context for 2026F, typical sites of service, and how the code functions in documentation workflows for diabetic retinopathy imaging. The publication provides benchmarks for usage patterns, summaries of policy considerations affecting coverage and reimbursement, and guidance on associated documentation elements necessary to support claims. Where specific data elements were not provided in the input, the report notes that those items are not available and focuses on national applicability and clinical relevance.
Billing Code Overview
CPT code 2026F describes when an ophthalmology or optometry provider uses other eye imaging to validate seven-standard-field stereoscopic retinal photographs in a patient with diabetic retinopathy and documents the findings in the patient’s chart.
Service Type: Ophthalmic imaging validation and documentation
Typical Site of Service: Ophthalmology or optometry clinic; outpatient eye imaging center
Data not available in the input for payers, modifiers, taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with longstanding type 2 diabetes mellitus presents to an ophthalmology clinic for diabetic retinopathy surveillance. The patient previously had screening 7-standard-field stereoscopic retinal photography demonstrating mild to moderate nonproliferative diabetic retinopathy. The ophthalmology provider orders additional ocular imaging (for example, wide-field fundus imaging, OCT fundus montage, or fluorescein angiography derived imaging) to validate and compare the prior 7-standard-field stereoscopic photographic findings. The provider reviews the images, documents correlation or discrepancy with the prior 7-standard-field stereo photos, and records a validated assessment of diabetic retinopathy severity and any macular edema in the patient’s medical record. Typical site of service is an outpatient ophthalmology or optometry clinic or an ambulatory imaging suite. Service type is diagnostic retinal imaging review and validation with documentation in the medical record.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | When a distinct E/M visit is performed and documented on the same day as the imaging review |
26 | Professional component | When billing only the physician’s interpretation and report of the imaging (technical component billed separately) |
59 | Distinct procedural service | When a separate, distinct imaging or ophthalmic procedure is performed that is not ordinarily reported with the validation service |
76 | Repeat procedure by same physician | When the same imaging validation is repeated later the same day by the same provider |
77 | Repeat procedure by another physician | When a different physician repeats the validation the same day |
RT | Right side | When the service is specifically for the right eye and laterality coding is required |
LT | Left side | When the service is specifically for the left eye and laterality coding is required |
91 | Repeat clinical diagnostic laboratory test | Rarely used; only if a repeat imaging-based diagnostic test is reported under lab-like repeat rules (use per payer policy) |
XE | Separate encounter | When the imaging validation is performed during a separate encounter from other services (payer-dependent) |
XU | Unusual non-overlapping service | When service is distinct and not commonly billed together (payer-dependent) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207W00000X | Ophthalmology | Most common specialty performing retinal imaging validation and interpretation |
152W00000X | Optometry | Optometrists often perform retinal imaging and validation in outpatient clinics |
207K00000X | Retina Specialist (Ophthalmology) | Subspecialist for diabetic retinopathy interpretation and treatment |
207Y00000X | Cornea and External Disease (Ophthalmology) | May be involved in comprehensive care though less commonly for retina-specific interpretation |
2080P0207X | Physician Assistant - Ophthalmology | Mid-level providers who may document imaging review under supervising MD/DO |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
E11.319 | Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema | Common indication for retinal imaging validation to document presence and severity of diabetic retinopathy |
E11.321 | Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema | Imaging validation used to document macular involvement and guide follow-up |
E11.329 | Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema | Photographic validation supports staging and surveillance intervals |
E11.341 | Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema | Validation helps determine progression and need for intervention |
E11.349 | Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema | Used for surveillance imaging and documentation of progression |
E11.351 | Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema | Imaging validation critical to identify high-risk features and treatment planning |
E11.39 | Type 2 diabetes mellitus with other diabetic ophthalmic complication | Captures other diabetic eye complications that may be assessed during validation |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
92250 | Fundus photography with interpretation and report | Often performed before or alongside validation to obtain the retinal photographs that are reviewed or compared to 7-standard-field stereo photos |
92235 | Fluorescein angiography (with interpretation and report) | Performed when vascular detail or leakage assessment is needed to supplement or validate stereoscopic photo findings |
92134 | Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report (OCT) | Used to evaluate macular edema and structural retinal changes that complement photographic validation |
67028 | Intravitreal injection of a pharmacologic agent | May follow imaging validation if treatment for diabetic macular edema or proliferative disease is indicated |
99000 | Handling and/or conveyance of specimen for transfer from physician to lab | Occasionally used for ancillary processes related to specialized imaging assays or specimens (payer-dependent) |
99499 | Unlisted evaluation and management service | Used rarely if an atypical documentation-only service related to imaging validation does not have a specific CPT code |